Novel Ocular Drug Delivery Systems: An Update on Microemulsions
- PMID: 32255728
- DOI: 10.1089/jop.2019.0135
Novel Ocular Drug Delivery Systems: An Update on Microemulsions
Abstract
Sufficient ophthalmic drug delivery is still challenging for pharmaceutical technologists, despite various scientific efforts. Several ocular drug carriers have been designed to enhance bioavailability by prolonging the drug retention time. One of the current encouraging approaches is the utilization of colloidal carriers with the characteristic submicron-nanometer size. Microemulsions (MEs) are such colloid systems that present sizes between 5 and 200 nm with significant thermodynamic stability and low surface tension. In addition, MEs as topical ocular carriers can lead to great ocular drug adsorption due to their enhanced retention time. Furthermore, considering that MEs are stable for long time and various temperatures, their ocular application is of great interest. The aim of this study is to cover basic physicochemical principals of ocular MEs such as their possible size, stability, and therapeutic efficacy against various eye disorders. Thus, a comprehensive review for ocular drug delivery systems in the form of MEs that show promising characteristics as their stability and therapeutic efficiency is performed.
Keywords: eye; microemulsion; ocular; ocular drug delivery; ophthalmic.
Similar articles
-
Micelles: Promising Ocular Drug Carriers for Anterior and Posterior Segment Diseases.J Ocul Pharmacol Ther. 2020 Jul/Aug;36(6):323-341. doi: 10.1089/jop.2019.0109. Epub 2020 Apr 20. J Ocul Pharmacol Ther. 2020. PMID: 32310723 Review.
-
Recent advances in ocular drug delivery.Drug Dev Ind Pharm. 2013 Nov;39(11):1599-617. doi: 10.3109/03639045.2012.736515. Epub 2012 Nov 16. Drug Dev Ind Pharm. 2013. PMID: 23153114 Review.
-
Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability.J Pharm Sci. 2012 Oct;101(10):3833-44. doi: 10.1002/jps.23251. Epub 2012 Jul 5. J Pharm Sci. 2012. PMID: 22767401
-
Microemulsions as ocular drug delivery systems: recent developments and future challenges.Prog Retin Eye Res. 2002 Jan;21(1):15-34. doi: 10.1016/s1350-9462(01)00017-9. Prog Retin Eye Res. 2002. PMID: 11906809 Review.
-
Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.Pharm Nanotechnol. 2024;12(3):229-250. doi: 10.2174/2211738511666230816090046. Pharm Nanotechnol. 2024. PMID: 37587812 Review.
Cited by
-
The Use of Polymer Blends in the Treatment of Ocular Diseases.Pharmaceutics. 2022 Jul 7;14(7):1431. doi: 10.3390/pharmaceutics14071431. Pharmaceutics. 2022. PMID: 35890326 Free PMC article. Review.
-
Preparation and Evaluation of Azelaic Acid Topical Microemulsion Formulation: In Vitro and In Vivo Study.Pharmaceutics. 2021 Mar 19;13(3):410. doi: 10.3390/pharmaceutics13030410. Pharmaceutics. 2021. PMID: 33808836 Free PMC article.
-
Current Advances in Nano-Based and Polymeric Stimuli-Responsive Drug Delivery Targeting the Ocular Microenvironment: A Review and Envisaged Future Perspectives.Polymers (Basel). 2022 Aug 30;14(17):3580. doi: 10.3390/polym14173580. Polymers (Basel). 2022. PMID: 36080651 Free PMC article. Review.
-
Microemulsion-Based Media in Nose-to-Brain Drug Delivery.Pharmaceutics. 2021 Feb 2;13(2):201. doi: 10.3390/pharmaceutics13020201. Pharmaceutics. 2021. PMID: 33540856 Free PMC article. Review.
-
Recent advances in medicinal compounds related to corneal crosslinking.Front Pharmacol. 2023 Sep 29;14:1232591. doi: 10.3389/fphar.2023.1232591. eCollection 2023. Front Pharmacol. 2023. PMID: 37841929 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous